Trinity Biotech (TRIB) has released an update.
An independent audit of Waveform Technologies, Inc., a subsidiary of Trinity Biotech Plc, has confirmed that the company’s financial statement for assets acquired and liabilities assumed as of January 30, 2024, is fairly presented in accordance with International Financial Reporting Standards. The audit, conducted by Grant Thornton, examined the company’s non-current and current assets, totaling $24,440,000, against liabilities assumed of $50,000. The report emphasizes that the financial statement is prepared specifically for SEC compliance and may not represent the full financial position of the company.
For further insights into TRIB stock, check out TipRanks’ Stock Analysis page.
